Pregn-4-en-3-one,20-hydroxy-, (20S)- cas no:145-14-2

NamePregn-4-en-3-one,20-hydroxy-, (20S)-
CAS145-14-2
SynonymsPregn-4-en-3-one,20a-hydroxy- (8CI);20(S)-Hydroxyprogesterone; 20-Hydroxypregn-4-en-3-one; 20a-Dihydroprogesterone; 20a-Hydroxy-4-pregnen-3-one; 20a-Hydroxy-D4-pregnen-3-one; 20a-Hydroxydihydroprogesterone; 20a-Hydroxypregn-4-en-3-one; 20a-Hydroxyprogesterone; 20a-Progerol; 4-Pregnen-3-one-20a-ol; NSC 68630; Pregn-4-en-20a-ol-3-one; Pregn-4-ene-20a-ol-3-one; Progesterol-20a; D4-Pregnen-20a-ol-3-one; D4-Pregnene-20a-ol-3-one
EINECS(EC#)205-649-5
Molecular FormulaC21H32 O2
Molecular Weight316.48

refractive index1.549

CHEMICAL IDENTIFICATION

RTECS NUMBER :

TU5559900

CHEMICAL NAME :

Pregn-4-en-3-one, 20-alpha-hydroxy-

CAS REGISTRY NUMBER :

145-14-2

BEILSTEIN REFERENCE NO. :

2220567

LAST UPDATED :

199612

DATA ITEMS CITED :

2

MOLECULAR FORMULA :

C21-H32-O2

MOLECULAR WEIGHT :

316.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Subcutaneous

DOSE :

40 mg/kg

SEX/DURATION :

female 10 day(s) pre-mating

TOXIC EFFECTS :

Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated)

MUTATION DATA

TYPE OF TEST :

DNA inhibition

TEST SYSTEM :

Human Lymphocyte

DOSE/DURATION :

10 mg/L

REFERENCE :

AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 127,151,1977